Agenus (AGEN) Profit After Tax Growth (5y) (2015 - 2026)

Agenus (AGEN) Profit After Tax Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Agenus 234.10 Mn 199.10 Mn 33.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.16%
Dec 31, 2025 22.41%
Sep 30, 2025 26.49%
Jun 30, 2025 9.06%
Mar 31, 2025 10.25%
Dec 31, 2024 -8.69%
Sep 30, 2024 -7.75%
Jun 30, 2024 -1.11%
Mar 31, 2024 -41.33%
Dec 31, 2023 0.11%
Sep 30, 2023 -13.85%
Jun 30, 2023 -23.85%
Mar 31, 2023 -5.49%
Dec 31, 2022 -16.16%
Sep 30, 2022 -9.01%
Jun 30, 2022 -9.20%
Mar 31, 2022 -24.23%
Dec 31, 2021 -20.95%
Sep 30, 2021 44.72%
Jun 30, 2021 -24.29%